Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Europe's research commissioner should develop a bolder vision for his 'European Research Area', while explicitly addressing the conflicting demands on the European Union's research programme.
A new report provides a useful overview of issues surrounding the mutual and conflicting interests of academic researchers and business. Its recommendations should inspire caution rather than unalloyed enthusiasm.
With a federal election due in Australia this year, the two main political parties are vying over how best to stimulate the growth of biotechnology. But the quest for a knowledge-intense economy requires long-term investment and management.
The drive to acquire intellectual property from research contributes to the wealth of nations, but can also undermine science if carried to excess. Exaggerated claims threaten to undermine the funding and climate of basic research.
Chemistry suffers from multiple image problems. Chemists working at its boundaries should acknowledge and celebrate their roots, while those at its core have much to celebrate too.
The US legislature is bereft of objective guidance on issues that underpin much of its work. A congressional Office of Technology Assessment should be reinstated as soon as possible, on a solid basis of bipartisan support.
Studies of past global change from sediments and ice cores have revealed a rich diversity of gradual and rapid perturbations. But more should be done to make the data usable by the research community as a whole.
Biologists should involve themselves in the debate over biological weapons — both to ensure that we have the means to counter the threats that such weapons pose and to help keep those threats in perspective.
The South African government at last has an opportunity to fight AIDS with drugs at reduced prices without fear of legal action. The country has the capacity to make significant progress. The government should make use of it.
After a slow start, progress towards developing public repositories for gene expression data is poised to accelerate. For the many biologists working with DNA microarrays, that should be welcome news.
The Human Genome Organisation was both a cheer-leader and a coordinator for genomics. But proteomics is a different beast, and the fledgling Human Proteome Organisation will struggle to find a similar role.